"ovarian borderline tumor histologic" trang 10 - tải miễn phí từ tailieunhanh
MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib

MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib
12    34    1
Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: Analysis of laboratory measures from electronic medical records

Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: Analysis of laboratory measures from electronic medical records
11    44    1
MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity

MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity
8    69    1
Identification of therapeutic targets applicable to clinical strategies in ovarian cancer

Identification of therapeutic targets applicable to clinical strategies in ovarian cancer
13    41    1
Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect”

Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect”
9    57    1
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer

Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer
14    44    1
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models

Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models
13    81    1
Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: A competing risk analysis

Front-line intraperitoneal versus intravenous chemotherapy in stage III-IV epithelial ovarian, tubal, and peritoneal cancer with minimal residual disease: A competing risk analysis
8    35    1
Antitumor effects of cecropin B-LHRH’ on drug-resistant ovarian and endometrial cancer cells

Antitumor effects of cecropin B-LHRH’ on drug-resistant ovarian and endometrial cancer cells
9    61    1
The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): Study protocol for a randomized controlled trial and progress

The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): Study protocol for a randomized controlled trial and progress
7    77    1
Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer

Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer
16    45    1
Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival

Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival
11    28    1
Demethylation of HIN-1 reverses paclitaxelresistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway

Demethylation of HIN-1 reverses paclitaxelresistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway
12    57    1
Prior oral contraceptive use in ovarian cancer patients: Assessing associations with overall and progression-free survival

Prior oral contraceptive use in ovarian cancer patients: Assessing associations with overall and progression-free survival
7    75    1
Impact of liver cirrhosis due to chronic hepatitis C viral infection on the outcome of ovarian cancer: A prospective study

Impact of liver cirrhosis due to chronic hepatitis C viral infection on the outcome of ovarian cancer: A prospective study
7    41    1
Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospitalbased case - control study

Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospitalbased case - control study
8    76    1
Phage display screening identifies a novel peptide to suppress ovarian cancer cells in vitro and in vivo in mouse models

Phage display screening identifies a novel peptide to suppress ovarian cancer cells in vitro and in vivo in mouse models
12    44    1
Under-treatment of elderly patients with ovarian cancer: A population based study

Under-treatment of elderly patients with ovarian cancer: A population based study
10    75    1
Lesion distribution characteristics of deep infiltrating endometriosis with ovarian endometrioma: An observational clinical study

Lesion distribution characteristics of deep infiltrating endometriosis with ovarian endometrioma: An observational clinical study
7    50    1
Exploratory study of a screening measure for polycystic ovarian syndrome, quality of life assessment, and neuropsychological evaluation

Exploratory study of a screening measure for polycystic ovarian syndrome, quality of life assessment, and neuropsychological evaluation
12    41    2